Dentsply Sirona Inc XRAY

$8.67 -0.07 (-0.80%)

Valuation

Market cap
1,728,399,000
Revenue TTM
$3,680,000,000
Net income TTM
$-598,000,000
PE ratio
6.11
Forward PE
6.26
Profit margin
-16.25%
Debt to equity
1.48

Trading

Volume
5,786,400
Avg volume
4,569,664
Day's range
$8.59 – $8.85
Shares out
199,354,000
Stochastic %K
6%
Beta
0.87
Analysts
Sell
Price target
$13.41

Price

Company profile

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equip...

Show more

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
844 848 0137
Website
https://www.dentsplysirona.com
Address
13320 Ballantyne Corporate Place, Charlotte, United States

Latest news

No headlines yet.

Stocktwits

g_man_ Oct 2, 4:13 PM
$XRAY where’s the bottom?
0 replies
matmlg Oct 2, 2:32 PM
$XRAY this has been my worst trade all year. Beautiful 5 year chart here. Hoping earnings call brings a turnaround starting next quarter.
0 replies
g_man_ Oct 2, 10:50 AM
$XRAY buy as much as possible
0 replies
residentevil51 Sep 30, 5:17 PM
$XRAY if this goes to $3; i will be so excited
0 replies
g_man_ Sep 30, 4:18 PM
$XRAY this is load up levels no?
0 replies
residentevil51 Sep 29, 4:49 PM
$XRAY hopefully this hits 5-6 dollars, or maybe even 3-4 dollars
0 replies
RavaK Sep 29, 11:08 AM
$XRAY they removed fluoride from the water……………………. Just wait a few years till all the MAHA folks (sadly I mean children) start screaming in dental pain - this stock is going only way and that’s up. Nothing but buying opportunities here imho. The insiders bought heavily when it was $10.00 recently. Don’t you think they are doing again now?
2 replies
matmlg Sep 28, 2:07 PM
$XRAY what a dud this has been. With $QXO and XRAY. turnaround Tom Hayes not looking too good here....
3 replies